Cargando…
Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2
BACKGROUND: Platelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream. The C-type lectin DC-SIGN and the novel HIV attachment factor CLEC-2 are expressed by platelets and facil...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885308/ https://www.ncbi.nlm.nih.gov/pubmed/20482880 http://dx.doi.org/10.1186/1742-4690-7-47 |
_version_ | 1782182367519047680 |
---|---|
author | Chaipan, Chawaree Steffen, Imke Tsegaye, Theodros Solomon Bertram, Stephanie Glowacka, Ilona Kato, Yukinari Schmökel, Jan Münch, Jan Simmons, Graham Gerardy-Schahn, Rita Pöhlmann, Stefan |
author_facet | Chaipan, Chawaree Steffen, Imke Tsegaye, Theodros Solomon Bertram, Stephanie Glowacka, Ilona Kato, Yukinari Schmökel, Jan Münch, Jan Simmons, Graham Gerardy-Schahn, Rita Pöhlmann, Stefan |
author_sort | Chaipan, Chawaree |
collection | PubMed |
description | BACKGROUND: Platelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream. The C-type lectin DC-SIGN and the novel HIV attachment factor CLEC-2 are expressed by platelets and facilitate HIV transmission from platelets to T-cells. Here, we studied the molecular mechanisms behind CLEC-2-mediated HIV-1 transmission. RESULTS: Binding studies with soluble proteins indicated that CLEC-2, in contrast to DC-SIGN, does not recognize the viral envelope protein, but a cellular factor expressed on kidney-derived 293T cells. Subsequent analyses revealed that the cellular mucin-like membranous glycoprotein podoplanin, a CLEC-2 ligand, was expressed on 293T cells and incorporated into virions released from these cells. Knock-down of podoplanin in 293T cells by shRNA showed that virion incorporation of podoplanin was required for efficient CLEC-2-dependent HIV-1 interactions with cell lines and platelets. Flow cytometry revealed no evidence for podoplanin expression on viable T-cells and peripheral blood mononuclear cells (PBMC). Podoplanin was also not detected on HIV-1 infected T-cells. However, apoptotic bystander cells in HIV-1 infected cultures reacted with anti-podoplanin antibodies, and similar results were obtained upon induction of apoptosis in a cell line and in PBMCs suggesting an unexpected link between apoptosis and podoplanin expression. Despite the absence of detectable podoplanin expression, HIV-1 produced in PBMC was transmitted to T-cells in a CLEC-2-dependent manner, indicating that T-cells might express an as yet unidentified CLEC-2 ligand. CONCLUSIONS: Virion incorporation of podoplanin mediates CLEC-2 interactions of HIV-1 derived from 293T cells, while incorporation of a different cellular factor seems to be responsible for CLEC-2-dependent capture of PBMC-derived viruses. Furthermore, evidence was obtained that podoplanin expression is connected to apoptosis, a finding that deserves further investigation. |
format | Text |
id | pubmed-2885308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28853082010-06-15 Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 Chaipan, Chawaree Steffen, Imke Tsegaye, Theodros Solomon Bertram, Stephanie Glowacka, Ilona Kato, Yukinari Schmökel, Jan Münch, Jan Simmons, Graham Gerardy-Schahn, Rita Pöhlmann, Stefan Retrovirology Research BACKGROUND: Platelets are associated with HIV in the blood of infected individuals and might modulate viral dissemination, particularly if the virus is directly transmitted into the bloodstream. The C-type lectin DC-SIGN and the novel HIV attachment factor CLEC-2 are expressed by platelets and facilitate HIV transmission from platelets to T-cells. Here, we studied the molecular mechanisms behind CLEC-2-mediated HIV-1 transmission. RESULTS: Binding studies with soluble proteins indicated that CLEC-2, in contrast to DC-SIGN, does not recognize the viral envelope protein, but a cellular factor expressed on kidney-derived 293T cells. Subsequent analyses revealed that the cellular mucin-like membranous glycoprotein podoplanin, a CLEC-2 ligand, was expressed on 293T cells and incorporated into virions released from these cells. Knock-down of podoplanin in 293T cells by shRNA showed that virion incorporation of podoplanin was required for efficient CLEC-2-dependent HIV-1 interactions with cell lines and platelets. Flow cytometry revealed no evidence for podoplanin expression on viable T-cells and peripheral blood mononuclear cells (PBMC). Podoplanin was also not detected on HIV-1 infected T-cells. However, apoptotic bystander cells in HIV-1 infected cultures reacted with anti-podoplanin antibodies, and similar results were obtained upon induction of apoptosis in a cell line and in PBMCs suggesting an unexpected link between apoptosis and podoplanin expression. Despite the absence of detectable podoplanin expression, HIV-1 produced in PBMC was transmitted to T-cells in a CLEC-2-dependent manner, indicating that T-cells might express an as yet unidentified CLEC-2 ligand. CONCLUSIONS: Virion incorporation of podoplanin mediates CLEC-2 interactions of HIV-1 derived from 293T cells, while incorporation of a different cellular factor seems to be responsible for CLEC-2-dependent capture of PBMC-derived viruses. Furthermore, evidence was obtained that podoplanin expression is connected to apoptosis, a finding that deserves further investigation. BioMed Central 2010-05-19 /pmc/articles/PMC2885308/ /pubmed/20482880 http://dx.doi.org/10.1186/1742-4690-7-47 Text en Copyright ©2010 Chaipan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Chaipan, Chawaree Steffen, Imke Tsegaye, Theodros Solomon Bertram, Stephanie Glowacka, Ilona Kato, Yukinari Schmökel, Jan Münch, Jan Simmons, Graham Gerardy-Schahn, Rita Pöhlmann, Stefan Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 |
title | Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 |
title_full | Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 |
title_fullStr | Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 |
title_full_unstemmed | Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 |
title_short | Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2 |
title_sort | incorporation of podoplanin into hiv released from hek-293t cells, but not pbmc, is required for efficient binding to the attachment factor clec-2 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885308/ https://www.ncbi.nlm.nih.gov/pubmed/20482880 http://dx.doi.org/10.1186/1742-4690-7-47 |
work_keys_str_mv | AT chaipanchawaree incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT steffenimke incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT tsegayetheodrossolomon incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT bertramstephanie incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT glowackailona incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT katoyukinari incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT schmokeljan incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT munchjan incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT simmonsgraham incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT gerardyschahnrita incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 AT pohlmannstefan incorporationofpodoplaninintohivreleasedfromhek293tcellsbutnotpbmcisrequiredforefficientbindingtotheattachmentfactorclec2 |